VIX
46
-3
VFC
42
-3
DUK
59
5
HST
32
-2
CB
57
3
HRL
45
12
FLR
58
-4
SWK
42
-3
GD
53
3
AXP
67
-3
WDC
61
-2
SYF
60
-2
GILD
63
-2
FRT
56
-2
CLX
48
3
EW
46
2
GM
71
6
MAR
68
2
KR
61
2
MDT
60
3
VIX
46
-3
VFC
42
-3
DUK
59
5
HST
32
-2
CB
57
3
HRL
45
12
FLR
58
-4
SWK
42
-3
GD
53
3
AXP
67
-3
WDC
61
-2
SYF
60
-2
GILD
63
-2
FRT
56
-2
CLX
48
3
EW
46
2
GM
71
6
MAR
68
2
KR
61
2
MDT
60
3
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
$42.60
Seasonality Move:
6.22%

7 Day Trial

ALL ACCESS PASS

$ 7

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 23.7% based on the past 15 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 11 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.33%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $43.02. The Score for BIB is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 23.7% based on the past 15 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
39
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 11 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.33%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
33.78

Prediction Charts

Market Cap:
0
Price in USD:
43.02
Volume:
8.3K
Beta:
1.83

Technical Analysis

SMA50:
44.37
SMA100:
49.17
SMA200:
55.28
52-Wk Change:
-22.64%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 43.02 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-12 40.09 43.10 43.42 40.09
May-13 42.01 41.48 42.01 41.05
May-14 41.66 39.84 41.66 39.56
May-15 39.85 41.61 41.61 39.75
May-16 41.61 42.96 42.96 41.48
May-19 42.91 43.95 43.95 42.91
May-20 43.73 45.30 45.30 43.63
May-21 44.74 43.38 44.75 43.15
May-22 43.36 43.10 43.49 42.57
May-23 42.68 43.24 43.24 42.50
May-27 43.74 44.05 44.45 43.71
May-28 43.88 43.11 43.88 43.11
May-29 44.10 44.95 44.99 44.02
May-30 42.38 43.02 43.21 42.09

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.